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Background
In the biopharmaceutical industry, the control of glyco-
sylation to satisfy the quality consistency of recombinant
proteins produced during a process has become an
important issue. Indeed, the glycosylation pattern of
recombinant proteins could be influenced by different
factors including the cell line used, environmental fac-
tors such as oxygenation, temperature, shear stresses,
extracellular pH... and the availability of nutrients.
As previously reported [1,2], the BDM medium is able
to support a better CHO cell growth and a higher IFN-g
production compared to RPMI medium supplemented
with serum. In addition, when BDM medium is used,
CHO cells are capable to maintain a high percentage of
doubly-glycosylated glycoforms of recombinant IFN-g
produced during the whole process. Conversely, mono-
glycosylated and non-glycosylated IFN-g forms increased
during batch cultures performed with RPMI serum
medium.
Iron is an important nutrient and is reported to sup-
port essential functions in cells. In this study, the impact
of different iron sources on the CHO cell growth, as
well as on the production and the glycosylation of a
human recombinant IFN-g were investigated.
Materials and methods
CHO cell cultures producing human recombinant IFN-g
(CHO 320: dhfr+, a2.6 ST-) were performed in Erlen-
meyer flasks (37°C, pH 7.2, 70 rpm) and in two different
media, namely RPMI and BDM [3]. Whereas RPMI is a
classical medium containing serum (5%), BDM is a che-
mically defined medium without any proteins or serum
addition. BDM was supplemented with 0.1% pluronic F-
68, 750 µM ethanolamine and 500 µM iron citrate.
IFN-g was quantified using an Elisa test. Glycosylation
macroheterogeneity of IFN-g was characterized by Wes-
tern Blotting (Amersham Biosciences) and each glyco-
form was quantified by densitometry as previously
described [2].
Results
CHO cell growth, IFN-g production and quality
CHO cell cultures producing human recombinant IFN-g
were cultivated in Erlenmeyer flasks, in both RPMI sup-
plemented with 5% SVF and BDM media. Kinetics per-
formed in BDM medium resulted in a higher maximal
viable cell density and IFN-g production compared to
RPMI medium (data not shown). In fact, the higher
IFN-g production by CHO cells observed in BDM med-
ium was mostly due to a higher cell density, since the
specific rate of IFN-g production (qIFN-g) was slighly
higher in the BDM medium than in the RPMI serum
medium.
In both media, three major molecular weight variants
(2N, 1N, 0N) were detected during the process with a
majority of IFN-g doubly-glycosylated (2N) whatever the
medium used (figure 1).
However, the quality of IFN-g remained constant dur-
ing the CHO cell cultures performed in BDM medium,
contrasting with the increase in the proportion of non-
glycosylated (0N) IFN-g to the detriment of the doubly-
glycosylated form (2N), during the time course of the
culture of CHO cells performed in RPMI serum
medium.
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any medium, provided the original work is properly cited.Addition of iron citrate in RPMI serum strongly affects the
cell growth, the production and the quality of IFN-g
Supplementation of RPMI serum medium with iron
citrate had a strong effect on kinetics of CHO cells pro-
ducing IFN-g. Indeed, a higher maximal viable CHO cell
d e n s i t ya sw e l la sah i g hI F N - g specific production rate
were measured, compared to kinetics of CHO cells per-
formed in RPMI serum medium without any supplemen-
tation (data not shown). In addition, supplementation of
RPMI with iron citrate resulted in a constant glycosyla-
tion pattern of IFN-g whereas an increase of non-glycosy-
lated IFN-g to the detriment of the doubly glycosylated
form was observed when CHO cells are were cultivated
in RPMI serum (Figure 1).
Addition of other bioavailable iron sources such as
ammoniacal ferric citrate or selenium iron citrate, in
RPMI serum medium resulted in the same phenom-
enon. However, when RPMI serum medium was supple-
mented with ferric-EDTA, a negative effect on the
production of IFN-g was observed (0.03 mg/10
8 cellules
vs. 0.07-0.08 mg/10
8 cellules using iron citrate, ammo-
niacal ferric citrate or iron citrate complexed to sele-
nium) despite the IFN-g macroglycoforms was
maintained constant in this condition (data not shown).
Conclusions
Addition of iron citrate to RPMI serum medium
improved cell growth, as well as IFN-g production.
Furthermore, the glycosylation pattern of IFN-g
remained constant when iron citrate was added in the
medium.
Addition of ammoniacal ferric citrate, iron citrate
complexed to selenium or ferric-EDTA to RPMI serum
medium also allowed to maintain a constant
macroglycosylation pattern of IFN-g produced during
batch cultures.
However, using ferric-EDTA in supplement of RPMI
serum, the specific production rate of IFN-g was lower
compared to values obtained when other iron sources as
named above were used.
Thus, the addition of a bioavailable iron source to cul-
ture media could improve the physiological cell proper-
ties as well as the quality of a recombinant protein
expressed.
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Figure 1 Proportion of IFN-g macroglycoforms produced by CHO cells cultivated in various media; RPMI serum, BDM and RPMI serum
supplemented with iron citrate.
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